Prostate News Archive
11-Apr-2007
PSA doubling time and indicator of recurrent prostate cancer (News-Medical-Net)
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. Identifying Osteoporosis In Men With Prostate Cancer (Science Daily)
Measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to a recent study. Prostate cancer: Treatments differ (Pioneer Press)
The question: Men diagnosed with prostate cancer have three treatment choices: radiation, surgery to remove the prostate gland or 'watchful waiting' - doing nothing unless symptoms worsen. Might one of these options offer a man with aggressive or high-grade cancer the likelihood of living longer? Prostate treatment choices will affect longevity (The Daily News)
THE QUESTION Men diagnosed with prostate cancer have three basic treatment choices: radiation, surgery to remove the prostate gland or "watchful waiting" -- doing nothing unless symptoms worsen. Might one of these options offer a man with aggressive or high-grade cancer the likelihood of living longer? PSA Doubling Predicts Prostate Cancer Recurrence (Science Daily)
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. ...
Back to Prostate News Archive
